Calcimedica, Inc. · NASDAQ:CALC
Avenue Venture Opportunities Fund II, L.P. reported a 6.70% stake in Calcimedica, Inc. (Schedule 13G)
Event Feb 28, 2025 · Filed May 28, 2025
Avenue Venture Opportunities Fund II, L.P. reported a 6.70% stake in Calcimedica, Inc., 1,000,358 shares, as a passive investor on Feb 28, 2025. Filed May 28, 2025 (Schedule 13G).
- Stake
- 6.70%
- Shares
- 1,000,358
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Avenue Venture Opportunities Fund II, L.P. | 6.70% | 1,000,358 |
| Avenue Capital Management II, L.P. | 6.70% | 1,000,358 |
| Avenue Venture Opportunities Partners II, LLC | 6.70% | 1,000,358 |
| GL Venture Opportunities Partners II, LLC | 6.70% | 1,000,358 |
| Marc Lasry | 6.70% | 1,000,358 |
Source
Related
- Calcimedica, Inc.
- Avenue Venture Opportunities Fund II, L.P.
- Calcimedica, Inc. shareholders
- Schedule 13G/A · Avenue Venture Opportunities Fund II, L.P. · Jun 25, 2026
- Schedule 13G/A · Avenue Venture Opportunities Fund II, L.P. · Sep 9, 2025
- Schedule 13G/A · Avenue Venture Opportunities Fund II, L.P. · Sep 2, 2025
- Schedule 13G · Stonepine Capital Management, LLC · Aug 25, 2026
- Schedule 13D/A · Alafi Capital Company LLC · Aug 24, 2026
- Schedule 13D/A · Bering Partners II GP, L.L.C. · Aug 21, 2026
- Schedule 13G · Woodline Partners LP · Aug 14, 2026
- Schedule 13G · Armistice Capital, LLC · Aug 14, 2026